Analysing the CRISPR arguments at the Federal Circuit
The UC v Broad Institute appeal hinges on whether the PTAB made any legal errors by deciding the case in favour of Broad without "substantial evidence", with observers believing an affirmance of the Board's ruling is most likely
The Federal Circuit heard oral arguments in University
of California (UC) v Broad Institute on April 30. A
decision is expected within 90 days.
The dispute involves the revolutionary gene-editing
biotechnology CRISPR-Cas9. UC filed its patent application in
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.